WBA (Walgreens Boots Alliance, Inc)
Insider Trading Activity
Every open-market purchase and sale reported by WBA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-28 | TIMOTHY C WENTWORTH | Chief Executive Officer | D | — | — |
| 2025-08-28 | Lanesha Minnix | EVP, Global CLO & Corp. Sec. | D | — | — |
| 2025-08-28 | Beth Amber L. Fabbri | SVP Chief Corp Affairs Officer | D | — | — |
| 2025-08-28 | Todd Heckman | SVP, Global Controller and CAO | D | — | — |
| 2025-08-28 | Elizabeth Burger | EVP, Global Chief HR Officer | D | — | — |
| 2025-08-28 | Tracey D Brown | EVP, Pres., Walgreens Retail | D | — | — |
| 2025-08-28 | Richard P. Gates | SVP, Chief Pharmacy Officer | D | — | — |
| 2025-08-28 | Ornella Barra | Chief Operating Officer, Int'l | D | — | — |
| 2025-08-28 | Mary Langowksi | EVP, President U.S. Healthcare | D | — | — |
| 2025-08-28 | Stefano Pessina | Executive Chairman of Board | D | — | — |
| 2025-08-28 | Manmohan Mahajan | EVP and Global CFO | D | — | — |
| 2025-08-15 | NANCY M SCHLICHTING | Director | A | — | — |
| 2025-08-15 | Robert Luther Huffines | Director | A | — | — |
| 2025-08-15 | Bryan C Hanson | Director | A | — | — |
| 2025-08-15 | VALERIE B JARRETT | Director | A | — | — |
| 2025-08-15 | GINGER L GRAHAM | Director | A | — | — |
| 2025-08-15 | William H Shrank | Director | A | — | — |
| 2025-08-15 | Inderpal S Bhandari | Director | A | — | — |
| 2025-08-15 | Thomas E Polen Jr | Director | A | — | — |
| 2025-08-15 | Janice M. Babiak | Director | A | — | — |
| 2025-08-15 | John Anthony Lederer | Director | A | — | — |
| 2025-07-11 | Robert Luther Huffines | Director | A | — | — |
| 2025-07-11 | VALERIE B JARRETT | Director | A | — | — |
| 2025-07-11 | John Anthony Lederer | Director | A | — | — |
| 2025-06-03 | Elizabeth Burger | EVP, Global Chief HR Officer | F | — | — |
| 2025-06-03 | Lanesha Minnix | EVP, Global CLO & Corp. Sec. | F | — | — |
| 2025-06-03 | Mary Langowksi | EVP, President U.S. Healthcare | F | — | — |
| 2025-04-29 | Stefano Pessina | Executive Chairman of Board | MIXED | — | — |
| 2025-04-18 | John Anthony Lederer | Director | A | — | — |
| 2025-04-18 | Robert Luther Huffines | Director | A | — | — |
| 2025-04-18 | VALERIE B JARRETT | Director | A | — | — |
| 2025-03-04 | Todd Heckman | SVP, Global Controller and CAO | F | — | — |
| 2025-03-04 | Beth Amber L. Fabbri | Chief Corp. Affairs Officer | F | — | — |
| 2025-03-04 | Tracey D Brown | EVP, Pres., Walgreens Retail | F | — | — |
| 2025-03-04 | Manmohan Mahajan | EVP and Global CFO | F | — | — |
| 2025-02-03 | John Anthony Lederer | Director | A | — | — |
| 2025-02-03 | Robert Luther Huffines | Director | A | — | — |
| 2025-02-03 | VALERIE B JARRETT | Director | A | — | — |
| 2024-11-05 | William H Shrank | Director | A | — | — |
| 2024-11-05 | NANCY M SCHLICHTING | Director | A | — | — |
| 2024-11-05 | Robert Luther Huffines | Director | A | — | — |
| 2024-11-05 | Bryan C Hanson | Director | A | — | — |
| 2024-11-05 | Thomas E Polen Jr | Director | A | — | — |
| 2024-11-05 | Elizabeth Burger | EVP, Global Chief HR Officer | A | — | — |
| 2024-11-05 | TIMOTHY C WENTWORTH | Chief Executive Officer | MIXED | — | — |
| 2024-11-05 | Inderpal S Bhandari | Director | A | — | — |
| 2024-11-05 | GINGER L GRAHAM | Director | A | — | — |
| 2024-11-05 | Tracey D Brown | EVP, Pres., Walgreens Retail | MIXED | — | — |
| 2024-11-05 | VALERIE B JARRETT | Director | A | — | — |
| 2024-11-05 | Todd Heckman | SVP, Global Controller and CAO | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 12,410,596 | — |
| — | Director | 4,579,100 | — |
| — | Co-Chief Operating Officer | 846,148 | — |
| — | Exec. Chairman of the Board | 656,782 | — |
| — | EVP and Global CFO | 527,430 | — |
| — | EVP, Chief Information Officer | 401,878 | — |
| — | CEO | 369,945 | — |
| — | EVP, Pres. U.S. Healthcare | 272,204 | — |
| — | EVP and Global CFO | 268,403 | — |
| — | EVP and Global CLO | 213,768 | — |
| — | EVP, Global Chief HR Officer | 188,829 | — |
| — | EVP and Global CIO | 132,689 | — |
| — | EVP, Chief Medical Officer | 116,992 | — |
| — | EVP and Global Chief HRO | 104,200 | — |
| — | EVP and President, Walgreen Co | 89,227 | — |
| — | Executive Vice President | 50,594 | — |
| — | Director | 50,000 | — |
| — | Director | 47,655 | — |
| — | EVP, Global CLO and CAO | 44,536 | — |
| — | EVP and Global CFO | 39,474 | — |
| — | Director | 37,961 | — |
| — | EVP, Global CAO and GC | 32,966 | — |
| — | EVP, Pres. Walgreens Pharmacy | 32,563 | — |
| — | Director | 28,269 | — |
| — | Director | 25,136 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the WBA quote page; the site-wide leaderboard is on the insider transactions hub.